Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy

Cong Li(Shandong University), Kyoko Hida(Sapporo University)
Breast Cancer Research
May 9, 2021
Cited by 52


Related Papers